| 查看: 161 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
帮忙翻译一下
|
|||
| The overall approach is based upon the “Life Cycle”or”V Model” for commissioning and qualification.The intent is to focus on the user requirements and up-front preliminary engineering so that the corresponding critical attributes of the equipment and system are defined.These attributes will be the basis for the testing procedures and respective acceptance criteria used in the commissioning and qualification activities.As part of this early engineering planning phase equipmnt and system provider activities,reviewed with the intent of”leveraging”the system providers, knowledge of the equipment/system,their quality practices in the design and build of the system, their support of FAT activities ,their installation and start-up expertise,their support of commissioning and SAT activities,and their qualification support.A number of the these activities will be monitored,reviewed,witnessed,and documented with the intent of reducing redundant testing during qualification. In addition,this will provide for a higher level of assurance that the equipment andsystems have been developed,built,installed and operate in accordance with pre-defined requirements. |
回复此楼» 猜你喜欢
使用MolAICal计算药物化学过滤器MCFs及MCE-18描述符
已经有0人回复
-
使用MolAICal发现蛋白受体潜在的活性口袋及位点
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有187人回复
-
华理药学学硕求调剂，总分324
已经有0人回复
-
澳门理工大学人工智能药物发现中心招收2026级博士研究生（申请-考核制）
已经有10人回复
-
药物检测中微生物限度计数结果判断
已经有0人回复
-
申博自荐
已经有2人回复
-
使用MolAICal生成小分子CHARMM力场拓扑和参数文件
已经有0人回复
-
请教执业药师报考的一些问题
已经有4人回复
-
扩散模型生成分子目前痛点，改进方向有哪些，论文创新性卡住了现在
已经有0人回复
-
求解答药物生成模型痛点以及创新点，扩散模型创新
已经有0人回复
